Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001741047-18-000001
Filing Date
2018-05-17
Accepted
2018-05-17 16:32:59
Documents
1
Effectiveness Date
2018-05-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6621
  Complete submission text file 0001741047-18-000001.txt   7642
Mailing Address 174 NASSAU ST #364 PRINCETON NJ 08542
Business Address 174 NASSAU ST #364 PRINCETON NJ 08542 908-720-6049
Calyptus Pharmaceuticals, Inc. (Filer) CIK: 0001741047 (see all company filings)

EIN.: 821792138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-312709 | Film No.: 18843463